| Literature DB >> 19127077 |
Ayse Fusun Kalpaklioglu1, Ayse Baccioglu Kavut, Ali Kemal Erdemoglu.
Abstract
We report a 41-year-old patient with multiple sclerosis (MS) who was successfully desensitized after she developed non-injection-site urticaria and angioedema due to interferon (IFN)-beta1a. Although a few cases of urticaria and anaphylaxis have been reported in the literature, to our knowledge this is the first report of a successful desensitization with IFN-beta1a. Desensitization with IFN-beta1a allowed us to continue with the administration of interferon-beta, which is a mainstay in treatment for MS. Copyright 2009 S. Karger AG, Basel.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19127077 DOI： 10.1159/000189203
Source DB: PubMed Journal: Int Arch Allergy Immunol ISSN： 1018-2438 Impact factor: 2.749